UnitedHealthCare
Myriad Genetics Stock Tanks After UnitedHealthcare Pulls Coverage of PGx Panels
The payor had been covering Myriad's GeneSight assay since 2019 but has decided there is not enough evidence showing this type of test is medically necessary.
UnitedHealthcare to Cover Whole-Genome Sequencing for Certain Non-Cancer Indications
The private payor published new coverage criteria for whole-genome sequencing tests for patients with a variety of non-cancer indications.
UnitedHealthcare Issues New Policy Expanding Coverage of Precision Oncology Diagnostics
The private payor added new coverage criteria for sequencing tests in approved companion diagnostic indications, as well as prostate cancer risk assays.
UnitedHealthcare to Cover Guardant360 for Approved CDx Indications in Lung, Breast Cancer
The move adds coverage for patients not eligible for coverage under Medicare, which currently pays for the test across all tumor types.